NF-κB and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages

A toxic dose of the nitric oxide (NO) donor S-nitrosoglutathione (GSNO; 1 mM) promoted apoptotic cell death of RAW 264.7 macrophages, which was attenuated by cellular preactivation with a nontoxic dose of GSNO (200 μM) or with lipopolysaccharide, interferon-γ, and NG-monomethyl-l-arginine (LPS/IFN-γ/NMMA) for 15 h. Protection from apoptosis was achieved by expression of cyclooxygenase-2 (Cox-2). Here we investigated the underlying mechanisms leading to Cox-2 expression. LPS/IFN-γ/NMMA prestimulation activated nuclear factor (NF)-κB and promoted Cox-2 expression. Cox-2 induction by low-dose GSNO demanded activation of both NF-κB and activator protein-1 (AP-1). NF-κB supershift analysis implied an active p50/p65 heterodimer, and a luciferase reporter construct, containing four copies of the NF-κB site derived from the murine Cox-2 promoter, confirmed NF-κB activation after NO addition. An NF-κB decoy approach abrogated not only Cox-2 expression after low-dose NO or after LPS/IFN-γ/NMMA but also inducible protection. The importance of AP-1 for Cox-2 expression and cell protection by low-level NO was substantiated by using the extracellular signal-regulated kinase inhibitor PD98059, blocking NO-elicited Cox-2 expression, but leaving the cytokine signal unaltered. Transient transfection of a dominant-negative c-Jun mutant further attenuated Cox-2 expression by low-level NO. Whereas cytokine-mediated Cox-2 induction relies on NF-κB activation, a low-level NO–elicited Cox-2 response required activation of both NF-κB and AP-1.

[1]  T. Hofmann,et al.  Co‐stimulatory effect of nitric oxide on endothelial NF‐κB implies a physiological self‐amplifying mechanism , 1998 .

[2]  B. Brüne,et al.  Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression , 1998, Oncogene.

[3]  A. Peitzman,et al.  Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.

[4]  E. Clementi,et al.  Nitric oxide effects on cell growth: GMP‐dependent stimulation of the AP‐1 transcription complex and cyclic GMP‐independent slowing of cell cycling , 1997, British journal of pharmacology.

[5]  A. von Knethen,et al.  Cyclooxygenase‐2: an essential regulator of NO‐mediated apoptosis , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  I. Adcock,et al.  Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆ , 1997 .

[7]  G. Yu,et al.  Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. , 1997, Biochemical pharmacology.

[8]  C. Harris,et al.  Interactive effects of nitric oxide and the p 53 tumor suppressor gene in carcinogenesis and tumor progression , 2004 .

[9]  J. Morrow,et al.  Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.

[10]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[11]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[12]  S. Murphy,et al.  Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. , 1997, The Biochemical journal.

[13]  G. Levy Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  R. Radi,et al.  Pathways of peroxynitrite oxidation of thiol groups. , 1997, The Biochemical journal.

[15]  J. Piette,et al.  Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. , 1997, The Biochemical journal.

[16]  Vijay R Baichwal,et al.  Apoptosis: Activate NF-κB or die? , 1997, Current Biology.

[17]  D. Candinas,et al.  Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment , 1997, Nature Medicine.

[18]  H. Lander An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[20]  J. Morrow,et al.  Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Baeuerle,et al.  Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. , 1996, Biochemical and biophysical research communications.

[22]  J. Jackson,et al.  Manipulation of Distinct NFκB Proteins Alters Interleukin-1β-induced Human Rheumatoid Synovial Fibroblast Prostaglandin E2 Formation* , 1996, The Journal of Biological Chemistry.

[23]  B. Wingerd,et al.  Prostanoid Receptors of Murine NIH 3T3 and RAW 264.7 Cells , 1996, The Journal of Biological Chemistry.

[24]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[25]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[26]  M. Currie,et al.  Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. , 1996, The Journal of clinical investigation.

[27]  A. Morrison,et al.  Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. , 1996, The Journal of clinical investigation.

[28]  John Calvin Reed,et al.  Nitric oxide induced poly(ADP‐ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl‐2 , 1996, FEBS letters.

[29]  B. Brüne,et al.  Nitric oxide (NO) in apoptotic versus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD+ content, and p53 accumulation. , 1996, Archives of biochemistry and biophysics.

[30]  M. Jacobson Reactive oxygen species and programmed cell death. , 1996, Trends in biochemical sciences.

[31]  B. Brüne,et al.  The dual role of S-nitrosoglutathione (GSNO) during thymocyte apoptosis. , 1996, Cellular signalling.

[32]  S. Srivastava,et al.  Tyrosine Kinase Inhibitors, Genistein and Herbimycin A, Do Not Block Interleukin-1 β-Induced Activation of NF-κB in Rat Mesangial Cells , 1996 .

[33]  Kei Yamamoto,et al.  Transcriptional Roles of Nuclear Factor B and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor -Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.

[34]  H. Herschman,et al.  v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.

[35]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[36]  Y. Tan,et al.  Involvement of a Putative Protein-tyrosine Phosphatase and IκB-α Serine Phosphorylation in Nuclear Factor κB Activation by Tumor Necrosis Factor (*) , 1995, The Journal of Biological Chemistry.

[37]  H. Pahl,et al.  Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.

[38]  B. Brüne,et al.  Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. , 1995, Molecular pharmacology.

[39]  J. Meinkoth,et al.  Nitric oxide and cGMP analogs activate transcription from AP‐1‐responsive promoters in mammalian cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  U. Siebenlist,et al.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Hunninghake,et al.  Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone. , 1994, The Journal of biological chemistry.

[42]  F. Staal,et al.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Herschman,et al.  v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element , 1994, Molecular and cellular biology.

[44]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[45]  J. Vane,et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Birrer,et al.  Mechanism of action of a dominant-negative mutant of c-Jun. , 1994, Oncogene.

[47]  M. Currie,et al.  Nitric oxide activates cyclooxygenase enzymes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[49]  J. Albina,et al.  Nitric oxide-mediated apoptosis in murine peritoneal macrophages. , 1993, Journal of immunology.

[50]  M. Birrer,et al.  Suppression of oncogene-induced transformation by a deletion mutant of c-jun. , 1993, Oncogene.

[51]  V. Souvannavong,et al.  Nitric oxide synthase induces macrophage death by apoptosis. , 1993, Biochemical and biophysical research communications.

[52]  D. Levine,et al.  Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. , 1993, Journal of immunology.

[53]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  S. Orrenius,et al.  Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. , 1989, Archives of biochemistry and biophysics.

[55]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[56]  K. Burton A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. , 1956, The Biochemical journal.

[57]  H. W. Sharma,et al.  Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis. , 1996, Anticancer research.

[58]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.

[59]  L. Ignarro Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.